Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-18

Clinical Trial Update: Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/Obesity (OOB) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating tirzepatide combined with cognitive-behavioral therapy for adults with alcohol use disorder and overweight/obesity; currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tirzepatide (tirzepatide)

Snippet

Sponsor: South West Sydney Local Health District | Conditions: Alcohol Use Disorder (AUD), Overweight or Obese | Phase 2 | Status: NOT_YET_RECRUITING